1Dhanashree S Dorge, 2Siya S Veer, 3Laxman R Bandgar, 4Madhuri S Nalawade, 5Kumudini R Pawar
1,2,3Students Abhinav Education Society’s College of Pharmacy (B.Pharm), NArhe, Pune-41
4,5Associate Professor Abhinav Education Society’s College of Pharmacy (Narhe) Pune-41
DOI : https://doi.org/10.47191/ijmra/v8-i02-38Google Scholar Download Pdf
ABSTRACT:
A nutritive strategy aimed at preventing, slowing, or halting the pathogenesis of disease represents a hopeful avenue that has garnered extensive research attention. A significant body of epidemiological evidence indicates that dietetic intake may play a pivotal part in the beginning and advancement of Alzheimer Disease or Alzheimer Dementia (AD). Modifiable environmental factors contributing to AD include potential metabolic disturbances arising from dietetic deficiencies or excesses, which may be addressed through nutritive subjoining or dietetic adjustments. Numerous nutritive subjoining encompass a variety of fitness advancing components, such as free-radical scavengers, vitamins, trace minerals, carbohydrates, and lipids, which may possess unique MOA that influence cytological well-being and rebirth, declining or especially target infectious routes involved in the progression of AD. The implementation of nutritive modifications is advantageous due to their cost-effectiveness, ease of application, social acceptability, and general safety, with minimal adverse effects in most instances. A wide range of nutritive interferences has been explored and continues assessed in the quest to identify effective additives, combinations of additives, or dietetic changes that can aid in the precaution and therapy of AD. This evaluation emphasizes some important nutritive complexes and dietetic transformations that have been examined in human populations, while also discussing the rationale for their potential benefits in the prohibition and management of AD.
KEYWORDS:Alzheimer Dementia (AD), Nutrition, Dietary supplements, Omega 3 fatty acids, Proteins.
REFERENCES1) Maurer, K., Volk, S., & Gerbaldo, H. (1997). Auguste D and Alzheimer's disease. Lancet (London, England), 349(9064), 1546–1549.
2) Cai, H., Cong, W. N., Ji, S., Rothman, S., Maudsley, S., & Martin, B. (2012). Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Current Alzheimer research, 9(1), 5–17.
3) https://www.medicalnewstoday.com/articles/159442
4) World Health Organization. (2016). ICD-10 International statistical classification of diseases and related health problems 10th revision Volume 2 Instruction manual Fifth edition 2016.
5) https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447
6) de Leon, M. J., Convit, A., DeSanti, S., Bobinski, M., George, A. E., Wisniewski, H. M., ... & Saint Louis, L. A. (1997). Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease. International Psychogeriatrics, 9(S1), 183-190.
7) Breijyeh, Z., & Karaman, R. (2020). Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules (Basel, Switzerland), 25(24), 5789.
8) Farlow, M. R., Lahiri, D. K., Poirier, J., Davignon, J., Schneider, L., & Hui, S. L. (1998). Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease. Neurology, 50(3), 669–677.
9) https://www.alzint.org/about/risk-factors-risk-reduction/
10) https://www.healthline.com/health/alzheimers-disease-complications
11) Kamboj, Parul & Thakur, Dr. Ajit. (2018). Pathophysiology and management of Alzheimer’s disease: an overview. Journal of Analytical & Pharmaceutical Research. 7.10.15406/japlr.2018.07.00230
12) Liu, J., Liu, Z., Zhang, Y., & Yin, F. (2015). A novel antagonistic role of natural compound icariin on neurotoxicity of amyloid β peptide. Indian Journal of Medical Research, 142(2), 190-195.
13) Kumar, A., Singh, A., & Ekavali (2015). A review on Alzheimer's disease pathophysiology and its management: an update. Pharmacological reports : PR, 67(2), 195–203.
14) Barage, S. H., & Sonawane, K. D. (2015). Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease. Neuropeptides, 52, 1–18.
15) Fei, H. X., Qian, C. F., Wu, X. M., Wei, Y. H., Huang, J. Y., & Wei, L. H. (2022). Role of micronutrients in Alzheimer's disease: Review of available evidence. World Journal of Clinical Cases, 10(22), 7631.
16) Liu, J. L., Fan, Y. G., Yang, Z. S., Wang, Z. Y., & Guo, C. (2018). Iron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications. Frontiers in neuroscience, 12, 632.
17) Ono, K., & Yamada, M. (2012). Vitamin A and Alzheimer's disease. Geriatrics & gerontology international, 12(2), 180-188.
18) Bhatti, A. B., Usman, M., Ali, F., & Satti, S. A. (2016). Vitamin Supplementation as an Adjuvant Treatment for Alzheimer's Disease. Journal of clinical and diagnostic research : JCDR, 10(8), OE07–OE11.
19) Gangwar, A. K., Rawat, A., Tiwari, S., Tiwari, S. C., Narayan, J., & Tiwari, S. (2015). Role of Vitamin-D in the prevention and treatment of Alzheimer's disease. Indian journal of physiology and pharmacology, 59(1), 94–99.
20) https://www.healthline.com/nutrition/9-foods-high-in-vitamin-d
21) Grimm, M. O., Mett, J., & Hartmann, T. (2016). The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease. International journal of molecular sciences, 17(11), 1785.
22) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751107/
23) https://www.healthline.com/nutrition/foods-high-in-vitamin-e
24) https://www.healthline.com/nutrition/foods-high-in-vitamin-k
25) https://www.healthline.com/nutrition/vitamin-c-foods
26) Lauer, A. A., Grimm, H. S., Apel, B., Golobrodska, N., Kruse, L., Ratanski, E., Schulten, N., Schwarze, L., Slawik, T., Sperlich, S., Vohla, A., & Grimm, M. O. W. (2022). Mechanistic Link between Vitamin B12 and Alzheimer's Disease. Biomolecules, 12(1), 129.
27) https://www.aan.com/PressRoom/Home/PressRelease/872
28) https://www.healthline.com/nutrition/vitamin-b12-foods
29) https://www.hsph.harvard.edu/nutritionsource/vitamin-b6/
30) https://www.healthline.com/health/vitamin-b6-foods
31) https://www.netmeds.com/health-library/post/vitamin-b3-functions-food-sources-deficiencies-and-toxicity
32) https://www.hsph.harvard.edu/nutritionsource/niacin-vitamin-b3/
33) https://www.mdpi.com/20763921/12/2/415#:~:text=A%20limited%20number%20of%
20human,brain%20amyloid%20accumulation%20%5B44%5D.
34) https://www.hsph.harvard.edu/nutritionsource/vitamin-b1/
35) https://www.nhs.uk/conditions/vitamins-and-minerals/iron/
36) https://ods.od.nih.gov/factsheets/SeleniumHealthProfessional/#:~:text=Brazil%20nuts%2C
%20seafood%2C%20meat%2C,regions%20%5B3%2C13%5D.
37) https://www.healthline.com/nutrition/best-foods-high-in-zinc
38) Caamaño, D., de la Garza, A., Beltrán-Ayala, P., & Chisanuano, A. M. (2016). Nutrition and neurodegenerative diseases: the role of carbohydrates and gluten. Int J Nutr Sci, 1(2), 1-6.
39) Gustafson, D. R., Bäckman, K., Scarmeas, N., Stern, Y., Manly, J. J., Mayeux, R., & Gu, Y. (2020). Dietary fatty acids and risk of Alzheimer's disease and related dementias: observations from the Washington Heights‐Hamilton Heights‐Inwood Columbia Aging Project (WHICAP). Alzheimer's & Dementia, 16(12), 1638-1649.
40) Derbyshire, E. (2018). Brain health across the lifespan: a systematic review on the role of omega-3 fatty acid supplements. Nutrients, 10(8), 1094.
41) Rahman, M. M., & Lendel, C. (2021). Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology. Molecular Neurodegeneration, 16(1), 59.
42) Sajjad, R., Arif, R., Shah, A. A., Manzoor, I., & Mustafa, G. (2018). Pathogenesis of Alzheimer’s disease: role of amyloid-beta and hyperphosphorylated tau protein. Indian J. Pharm. Sci, 80(4), 581-591.
43) Burckhardt, M., Watzke, S., Wienke, A., Langer, G., & Fink, A. (2020). Souvenaid for Alzheimer's disease. Cochrane Database of Systematic Reviews, (12).
44) https://www.netmeds.com/health-library/post/chyawanprash-benefits-uses-ingredients-method-dosage-and-side-effects
45) Roman, M. W. (2010). Axona®(Accera, Inc): a new medical food therapy for persons with Alzheimer's disease. Issues in mental health nursing, 31(6), 435-436.
Volume 08 Issue 02 February 2025
There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 08 Issue 03 (March 2025).
PUBLICATION DATES:
1) Last Date of Submission : 26 March 2025.
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.